For this reason, 15 novel antigens that were initially shown to be strongly and commonly recognized by CD8+ T cells from TB patients and individuals with latent M. tuberculosis infection (LTBI) in Portland, OR, and Uganda were selected (19, 20). This evidence concerns the gene CD8A and tuberculosis.